SciELO - Scientific Electronic Library Online

 
vol.30 número3Valor de la angiogénesis en relación a otros factores morfológicos en el carcinoma ductal infiltrante de mamaGliomatosis Cerebri: diagnóstico y tratamiento con temozolomida, a propósito de un caso índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Oncología (Barcelona)

versão impressa ISSN 0378-4835

Resumo

PROVENCIO, M. et al. PET and PET-CT in the staging and treatment of non-small cell lung cancer. Oncología (Barc.) [online]. 2007, vol.30, n.3, pp.28-40. ISSN 0378-4835.

Positron emission tomography with (18F)2-fluoro-2-deoxy-D-glucose (PET-FDG) is an imaging metabolic technique. PET-FDG is more precise than CT for the evaluation of mediastinal affectation of patients with non-small cell lung cancer, offering a high negative predictive value. It can detect occult metastases in 11 % of the patients, although the etiology of the extra-thoracic isolated receptions needs confirmation. Theoretically, PET-FDG can influence the planning volume of radiotherapy, mainly of patients with atelectasis. The quantification of the metabolic activity by means of PET-FDG is influenced by the size of the lesion, the glucose levels, and the time elapsed since the isotope injection. More clinical assays are needed to standardize PET execution procedures, its use as a prognostic factor and the evaluation of treatment response.

Palavras-chave : Positron emission tomography; PET-FDG; Non-small cell lung cancer.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons